Advertisement
Screener

VYOME HOLDINGS, INC. (HIND) Cost of Revenue

1.5 / 5 stars · 27/93 Roast Me

VYOME HOLDINGS, INC. Cost of Revenue

VYOME HOLDINGS, INC. (HIND) reported Cost of Revenue of $15.30 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Expense Statement › Cost of Sales

us-gaap:CostOfGoodsAndServicesSold · last filed 2026-08-12

  • VYOME HOLDINGS, INC. cost of goods and services sold for the quarter ending 2026-06-30 was $15.30K, a 40.52% decline year-over-year.
  • VYOME HOLDINGS, INC. cost of goods and services sold for the quarter ending 2026-03-31 was $14.95K, a 66.16% decline year-over-year.
  • VYOME HOLDINGS, INC. cost of goods and services sold for the quarter ending 2025-12-31 was $14.48K.
  • VYOME HOLDINGS, INC. cost of goods and services sold for the quarter ending 2025-09-30 was $16.58K, a 65.06% decline year-over-year.
  • VYOME HOLDINGS, INC. cost of goods and services sold for fiscal 2025 was $100.94K, a 62.88% increase from fiscal 2024.
  • VYOME HOLDINGS, INC. cost of goods and services sold for fiscal 2024 was $61.97K, a 98.02% decline from fiscal 2023.
  • VYOME HOLDINGS, INC. cost of goods and services sold for fiscal 2023 was $3.13M, a 29.47% decline from fiscal 2022.
  • VYOME HOLDINGS, INC. cost of goods and services sold for fiscal 2022 was $4.44M, a 15.50% decline from fiscal 2021.
Period endCost of Goods and Services Sold 3 monthCost of Goods and Services Sold 3 month as first filedCost of Goods and Services Sold 6 monthCost of Goods and Services Sold 6 month as first filedCost of Goods and Services Sold 9 monthCost of Goods and Services Sold 9 month as first filedCost of Goods and Services Sold 12 monthCost of Goods and Services Sold 12 month as first filed
2026-06-30$15.30K
10-Q · filed 2026-08-12
$30.24K
10-Q · filed 2026-08-12
$44.73K
derived: sum of 3 quarters · filed 2026-08-12
$61.30K
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$14.95K
10-Q · filed 2026-05-12
$29.43K
derived: sum of 2 quarters · filed 2026-05-12
$46.01K
derived: sum of 3 quarters · filed 2026-05-12
$71.73K
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$14.48K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$31.06K
derived: sum of 2 quarters · filed 2026-03-18
$56.78K
derived: sum of 3 quarters · filed 2026-08-12
$100.94K
10-K · filed 2026-03-18
2025-09-30$16.58K
10-Q · filed 2025-11-14
$42.30K
derived: sum of 2 quarters · filed 2026-08-12
$86.46K
10-Q · filed 2025-11-14
$85.13K
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$25.72K
10-Q · filed 2026-08-12
$643.00K
10-Q · filed 2025-08-14
$69.88K
10-Q · filed 2026-08-12
$1.07M
10-Q · filed 2025-08-14
$68.55K
derived: sum of 3 quarters · filed 2026-08-12
$115.99K
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$44.16K
10-Q · filed 2026-05-12
$432.00K
10-Q · filed 2025-05-20
$42.83K
derived: sum of 2 quarters · filed 2026-05-12
$90.27K
derived: sum of 3 quarters · filed 2026-05-12
$921.27K
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31-$1.33K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18
$46.11K
derived: sum of 2 quarters · filed 2026-03-18
$877.11K
derived: sum of 3 quarters · filed 2026-03-18
$61.97K
10-K · filed 2026-03-18
$2.95M
10-K · filed 2025-04-04
2024-09-30$47.44K
10-Q · filed 2025-11-14
$853.00K
10-Q · filed 2024-11-14
$878.44K
derived: sum of 2 quarters · filed 2025-11-14
$63.31K
10-Q · filed 2025-11-14
$2.46M
10-Q · filed 2024-11-14
$1.80M
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$831.00K
10-Q · filed 2025-08-14
$1.61M
10-Q · filed 2025-08-14
$1.75M
derived: sum of 3 quarters · filed 2025-08-14
$2.62M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$779.00K
10-Q · filed 2025-05-20
$919.00K
derived: sum of 2 quarters · filed 2025-05-20
$1.79M
derived: sum of 3 quarters · filed 2025-05-20
$2.85M
derived: sum of 4 quarters · filed 2025-05-20
2023-12-31$140.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-04
$1.01M
derived: sum of 2 quarters · filed 2025-04-04
$2.07M
derived: sum of 3 quarters · filed 2025-04-04
$3.13M
10-K · filed 2025-04-04
2023-09-30$867.00K
10-Q · filed 2024-11-14
$1.93M
derived: sum of 2 quarters · filed 2024-11-14
$2.99M
10-Q · filed 2024-11-14
$4.50M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30$1.06M
10-Q · filed 2024-08-14
$2.12M
10-Q · filed 2024-08-14
$3.63M
derived: sum of 3 quarters · filed 2024-08-14
$4.33M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$1.06M
10-Q · filed 2024-05-15
$2.57M
derived: sum of 2 quarters · filed 2024-05-15
$3.27M
derived: sum of 3 quarters · filed 2024-05-15
$4.28M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31$1.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
$2.21M
derived: sum of 2 quarters · filed 2024-04-01
$3.22M
derived: sum of 3 quarters · filed 2024-04-01
$4.44M
10-K · filed 2024-04-01
2022-09-30$697.00K
10-Q · filed 2023-11-09
$1.71M
derived: sum of 2 quarters · filed 2023-11-09
$2.93M
10-Q · filed 2023-11-09
$4.29M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$1.01M
10-Q · filed 2023-08-07
$2.23M
10-Q · filed 2023-08-07
$3.60M
derived: sum of 3 quarters · filed 2023-08-07
$5.17M
derived: sum of 4 quarters · filed 2023-08-07
2022-03-31$1.22M
10-Q · filed 2023-05-15
$2.59M
derived: sum of 2 quarters · filed 2023-05-15
$4.16M
derived: sum of 3 quarters · filed 2023-05-15
$5.54M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$1.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17
$2.94M
derived: sum of 2 quarters · filed 2023-04-17
$4.32M
derived: sum of 3 quarters · filed 2023-04-17
$5.25M
10-K · filed 2023-04-17
2021-09-30$1.57M
10-Q · filed 2022-11-14
$2.95M
derived: sum of 2 quarters · filed 2022-11-14
$3.89M
10-Q · filed 2022-11-14
$5.45M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30$1.38M
10-Q · filed 2022-08-19
$2.31M
10-Q · filed 2022-08-19
$3.88M
derived: sum of 3 quarters · filed 2022-08-19
$5.20M
derived: sum of 4 quarters · filed 2022-08-19
2021-03-31$937.00K
10-Q · filed 2022-05-23
$2.50M
derived: sum of 2 quarters · filed 2022-05-23
$3.82M
derived: sum of 3 quarters · filed 2022-05-23
$4.69M
derived: sum of 4 quarters · filed 2022-05-23
2020-12-31$1.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08
$2.89M
derived: sum of 2 quarters · filed 2022-04-08
$3.75M
derived: sum of 3 quarters · filed 2022-04-08
$5.04M
10-K · filed 2022-04-08
$1.00M
10-K · filed 2021-03-12
2020-09-30$1.32M
10-Q · filed 2021-11-12
$41.00K
10-Q · filed 2020-11-06
$2.19M
derived: sum of 2 quarters · filed 2021-11-12
$3.47M
10-Q · filed 2021-11-12
$1.00M
10-Q · filed 2020-11-06
$3.35M
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$865.00K
10-Q · filed 2021-08-16
$423.00K
10-Q · filed 2020-07-30
$2.15M
10-Q · filed 2021-08-16
$964.00K
10-Q · filed 2020-07-30
$2.03M
derived: sum of 3 quarters · filed 2021-08-16
$2.44M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31$541.00K
10-Q · filed 2021-05-12
$1.17M
derived: sum of 2 quarters · filed 2021-05-12
$1.58M
derived: sum of 3 quarters · filed 2021-05-12
$2.26M
derived: sum of 4 quarters · filed 2021-05-12
2019-12-31$627.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
$1.04M
derived: sum of 2 quarters · filed 2021-03-12
$1.72M
derived: sum of 3 quarters · filed 2021-03-12
$2.95M
10-K · filed 2021-03-12
2019-09-30$412.00K
10-Q · filed 2020-11-06
$1.09M
derived: sum of 2 quarters · filed 2020-11-06
$2.32M
10-Q · filed 2020-11-06
2019-06-30$679.00K
10-Q · filed 2020-07-30
$1.91M
10-Q · filed 2020-07-30
2019-03-31$1.23M
10-Q · filed 2020-06-19
2018-09-30$1.42M
10-Q · filed 2019-11-08
$3.15M
derived: sum of 2 quarters · filed 2019-11-08
$3.92M
10-Q · filed 2019-11-08
2018-06-30$1.73M
10-Q · filed 2019-07-24
$2.50M
10-Q · filed 2019-07-24
2018-03-31$769.00K
10-Q · filed 2019-05-10
2017-09-30$1.31M
10-Q · filed 2018-11-02
$2.30M
derived: sum of 2 quarters · filed 2018-11-02
$3.13M
10-Q · filed 2018-11-02
2017-06-30$990.00K
10-Q · filed 2018-08-02
$1.81M
10-Q · filed 2018-08-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Citius Pharmaceuticals, Inc. (CTXR)United States$0.016B-133.06
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36